DNA polymerase theta-mediated DNA repair is a functional dependency and therapeutic vulnerability in DNMT3A deficient leukemia cells
Le, B. V.; Vekariya, U.; Toma, M. M.; Nieborowska-Skorska, M.; Caron, M.-C.; Gozdecka, M.; Haydar, Z.; Walsh, M.; Ghosh, J.; Vaughan-Williams, E.; Podszywalow-Bartnicka, P.; Kukuyan, A.-M.; Ziolkowska, S.; Hadzijusufovic, E.; Chandramouly, G.; Piwocka, K.; Pomerantz, R.; Vassiliou, G. S.; Huntly, B. J.; Valent, P.; Bellacosa, A.; Masson, J.-Y.; Gupta, G. P.; Challen, G. A.; Skorski, T.
Show abstract
Myeloid malignancies carrying somatic DNMT3A mutations (DNMT3Amut) may be refractory to standard therapy. DNMT3Amut leukemia cells accumulate toxic DNA double strand breaks (DSBs) and stalled replication forks, rendering them dependent on DNA damage response (DDR). We report here that DNA polymerase theta (Pol{theta}), a key element in DSB repair by end-joining (TMEJ) and in fork restarting, is essential for survival and proliferation of DNMT3Amut leukemia cells. Pol{theta} is overexpressed in DNMT3Amut leukemia cells due to abrogation of PARP1 PARylation-dependent UBE2O E3 ligase-mediated ubiquitination and proteasomal degradation of Pol{theta}. In addition, PARP1-mediated recruitment of the SMARCAD1-MSH2/MSH3 repressive complex to DSBs was diminished in DNMT3Amut leukemia cells which facilitated loading of Pol{theta} on DNA damage and promoting TMEJ and replication fork restart. Pol{theta} inhibitors enhanced the anti-leukemic effects of standard drugs such as FLT3 kinase inhibitor quizartinib, cytarabine +/- doxorubicin, and etoposide in vitro and in mice with DNMT3Amut leukemia. Altogether, Pol{theta} is an attractive target in DNMT3Amut hematological malignancies.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- N-MYC regulates Cell Survival via eIF4G1 in inv(16) Acute Myeloid Leukemia 96%
- HMCES corrupts replication fork stability during base excision repair in homologous recombination deficient cells 96%
- Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug resistant gliomas 95%
Similar papers in this journal
- HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways 97%
- Topological stress triggers persistent DNA lesions in ribosomal DNA with ensuing formation of PML-nucleolar compartment 96%
- Functional Interrogation of HOXA9 Regulome in MLLr Leukemia via Reporter-based CRISPR/Cas9 screen 96%
Similar papers in this journal
- Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition 95%
- Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53 94%
- Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia 94%
Similar papers in this journal
- Loss of DHX36/G4R1, a G4 resolvase, drives genome instability and regulates innate immune gene expression in cancer cells 96%
- Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173A mice 96%
- Phosphorylation Status Of MUS81 Is A Modifier Of Olaparib Sensitivity In BRCA2-Deficient Cells 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.